Policy / Pricing Makary resigns, with Diamantas named as acting FDA commissioner Pharmaceutical TechnologyThe resignation comes after reports suggested the President was considering firing him.Read full story pharminent May 12, 2026 (Last updated: May 16, 2026) Pharmaceutical Technology The resignation comes after reports suggested the President was considering firing him. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Arvinas, Pfizer find new partner for ‘Protac’ breast cancer drugNext: Isomorphic Labs receives $2.1bn for AI drug development Related Stories Policy / Pricing Decoding Medicare Advantage Coding Intensity pharminent July 1, 2026 Policy / Pricing UK partners with Eli Lilly on obesity plan pharminent June 29, 2026 Policy / Pricing EFPIA report adds to pressures on EU drug pricing policy pharminent June 24, 2026
